Protein Engineering Market Size, Share, Trends, Growth Outlook

Protein Engineering Market is estimated to increase at a Compounded Annual Growth Rate of 17.3% CAGR over the forecast period from 2024 to 2030

The Protein Engineering Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Instruments, Reagents, Software & Services), By Technology (Rational Protein Design, Directed Evolution, Hybrid Approach, De Novo Protein Design, Others), By Protein (Insulin, Monoclonal Antibodies, Vaccines, Growth Factors, Colony Stimulating Factors, Coagulation Factors, Interferon, Others), By End-User (Academic Research Institutes, Contract Research Organizations (CROs), Pharmaceutical & Biotechnology Companies).

An Introduction to Protein Engineering Market in 2024

Protein Engineering is a multidisciplinary field focused on the design, modification, and optimization of proteins for various biomedical, biotechnological, and industrial applications. Through rational design, directed evolution, and computational modeling approaches, protein engineers manipulate protein sequences and structures to enhance stability, activity, specificity, and other desired properties. Protein engineering techniques enable the development of novel enzymes, therapeutic proteins, biosensors, and biomaterials with tailored functionalities and improved performance characteristics. As the demand for protein-based therapeutics, biocatalysts, and bioproducts grows, protein engineering continues to drive innovation in biopharmaceuticals, biotechnology, and synthetic biology, offering solutions to complex challenges in healthcare, agriculture, and environmental sustainability.

Market Trend: Growth in Protein-Based Therapeutics

A significant trend in the protein engineering market is the increasing growth of protein-based therapeutics. Protein engineering plays a pivotal role in the development of biopharmaceuticals, including monoclonal antibodies, therapeutic enzymes, cytokines, and fusion proteins. With the growing demand for targeted and personalized therapies, there has been a surge in the development of novel protein-based drugs for the treatment of various diseases, including cancer, autoimmune disorders, and rare genetic diseases. Protein engineering techniques enable the design, modification, and optimization of protein structures to enhance their therapeutic properties, such as specificity, affinity, stability, and pharmacokinetics. This trend reflects the expanding landscape of biologic drugs and the ongoing innovation in protein engineering technologies to meet the evolving needs of the pharmaceutical industry and address unmet medical needs.

Market Driver: Advancements in Synthetic Biology and Gene Editing Technologies

A key driver for the protein engineering market is the advancements in synthetic biology and gene editing technologies. Recent innovations in synthetic biology, CRISPR-Cas9 gene editing, and directed evolution techniques have revolutionized the field of protein engineering, enabling precise manipulation of protein sequences, structures, and functions. Synthetic biology tools facilitate the design and synthesis of custom DNA sequences encoding desired protein variants, while CRISPR-Cas9 systems enable targeted modifications of the genome to introduce specific mutations or modifications in protein-coding genes. Directed evolution methods, such as phage display and yeast surface display, allow for the generation of protein libraries and the selection of protein variants with improved properties through iterative screening and selection processes. These advancements in gene editing and synthetic biology technologies drive innovation and enable the development of next-generation protein therapeutics with enhanced efficacy, safety, and specificity, fueling market growth in protein engineering.

Market Opportunity: Expansion into Industrial Biotechnology and Enzyme Engineering

An emerging opportunity within the protein engineering market lies in the expansion into industrial biotechnology and enzyme engineering. Beyond the pharmaceutical sector, protein engineering has applications in various industries, including biofuels, agriculture, food processing, and environmental remediation. Enzyme engineering techniques enable the design and optimization of enzymes for industrial processes, such as biomass conversion, biocatalysis, and bioremediation. By engineering enzymes with tailored properties, such as substrate specificity, thermal stability, and resistance to inhibitors, companies can improve the efficiency, sustainability, and cost-effectiveness of industrial processes, leading to reduced environmental impact and increased product yields. Additionally, protein engineering offers opportunities to develop novel biocatalysts for the production of specialty chemicals, pharmaceutical intermediates, and high-value compounds. By leveraging protein engineering expertise and technologies, companies can tap into the growing market for industrial biotechnology and enzyme engineering, driving innovation and creating value in diverse sectors beyond healthcare.

Protein Engineering Market Share Analysis: Monoclonal Antibodies Protein Segment is the fastest growing segment over the forecast period to 2030

The monoclonal antibodies protein segment is experiencing the fastest growth within the protein engineering market. This growth is primarily driven by several factors. Monoclonal antibodies (mAbs) play a crucial role in therapeutic applications, including cancer treatment, autoimmune diseases, and infectious diseases, due to their specificity, efficacy, and low toxicity. As the demand for targeted therapies continues to rise, fueled by advancements in personalized medicine and immunotherapy, there is a growing need for novel and improved mAbs with enhanced therapeutic properties. Protein engineering technologies such as rational protein design, directed evolution, and de novo protein design enable the optimization of mAbs for increased specificity, affinity, and stability, as well as reduced immunogenicity. Moreover, the expanding pipeline of mAb-based drugs in development by pharmaceutical and biotechnology companies, coupled with the increasing outsourcing of protein engineering services to contract research organizations (CROs), further drives the growth of this segment. Additionally, academic research institutes contribute to the advancement of protein engineering technologies and the discovery of novel mAbs for various therapeutic applications. As stakeholders in the life sciences industry continue to invest in the development of innovative mAb-based therapies, the monoclonal antibodies protein segment emerges as the fastest-growing segment within the protein engineering market.

Protein Engineering Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAgilent Technologies Inc, Amgen Inc, Bio-Rad Laboratories Inc, Bruker Corp, Danaher Corp, GenScript Biotech Corp, Merck KGaA, PerkinElmer Inc, Thermo Fisher Scientific Inc, Waters Corp

Protein Engineering Market Segmentation

By Product
Instruments
Reagents
Software & Services
By Technology
Rational Protein Design
Directed Evolution
Hybrid Approach
De Novo Protein Design
Others
By Protein
Insulin
Monoclonal Antibodies
Vaccines
Growth Factors
Colony Stimulating Factors
Coagulation Factors
Interferon
Others
By End-User
Academic Research Institutes
Contract Research Organizations (CROs)
Pharmaceutical & Biotechnology Companies
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Protein Engineering Market Companies

Agilent Technologies Inc
Amgen Inc
Bio-Rad Laboratories Inc
Bruker Corp
Danaher Corp
GenScript Biotech Corp
Merck KGaA
PerkinElmer Inc
Thermo Fisher Scientific Inc
Waters Corp

Reasons to Buy the Protein Engineering Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Protein Engineering Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Protein Engineering Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Protein Engineering Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Protein Engineering Market Size Outlook, $ Million, 2021 to 2030
3.2 Protein Engineering Market Outlook by Type, $ Million, 2021 to 2030
3.3 Protein Engineering Market Outlook by Product, $ Million, 2021 to 2030
3.4 Protein Engineering Market Outlook by Application, $ Million, 2021 to 2030
3.5 Protein Engineering Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Protein Engineering Industry
4.2 Key Market Trends in Protein Engineering Industry
4.3 Potential Opportunities in Protein Engineering Industry
4.4 Key Challenges in Protein Engineering Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Protein Engineering Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Protein Engineering Market Outlook by Segments
7.1 Protein Engineering Market Outlook by Segments, $ Million, 2021- 2030
By Product
Instruments
Reagents
Software & Services
By Technology
Rational Protein Design
Directed Evolution
Hybrid Approach
De Novo Protein Design
Others
By Protein
Insulin
Monoclonal Antibodies
Vaccines
Growth Factors
Colony Stimulating Factors
Coagulation Factors
Interferon
Others
By End-User
Academic Research Institutes
Contract Research Organizations (CROs)
Pharmaceutical & Biotechnology Companies

8 North America Protein Engineering Market Analysis and Outlook To 2030
8.1 Introduction to North America Protein Engineering Markets in 2024
8.2 North America Protein Engineering Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Protein Engineering Market size Outlook by Segments, 2021-2030
By Product
Instruments
Reagents
Software & Services
By Technology
Rational Protein Design
Directed Evolution
Hybrid Approach
De Novo Protein Design
Others
By Protein
Insulin
Monoclonal Antibodies
Vaccines
Growth Factors
Colony Stimulating Factors
Coagulation Factors
Interferon
Others
By End-User
Academic Research Institutes
Contract Research Organizations (CROs)
Pharmaceutical & Biotechnology Companies

9 Europe Protein Engineering Market Analysis and Outlook To 2030
9.1 Introduction to Europe Protein Engineering Markets in 2024
9.2 Europe Protein Engineering Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Protein Engineering Market Size Outlook by Segments, 2021-2030
By Product
Instruments
Reagents
Software & Services
By Technology
Rational Protein Design
Directed Evolution
Hybrid Approach
De Novo Protein Design
Others
By Protein
Insulin
Monoclonal Antibodies
Vaccines
Growth Factors
Colony Stimulating Factors
Coagulation Factors
Interferon
Others
By End-User
Academic Research Institutes
Contract Research Organizations (CROs)
Pharmaceutical & Biotechnology Companies

10 Asia Pacific Protein Engineering Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Protein Engineering Markets in 2024
10.2 Asia Pacific Protein Engineering Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Protein Engineering Market size Outlook by Segments, 2021-2030
By Product
Instruments
Reagents
Software & Services
By Technology
Rational Protein Design
Directed Evolution
Hybrid Approach
De Novo Protein Design
Others
By Protein
Insulin
Monoclonal Antibodies
Vaccines
Growth Factors
Colony Stimulating Factors
Coagulation Factors
Interferon
Others
By End-User
Academic Research Institutes
Contract Research Organizations (CROs)
Pharmaceutical & Biotechnology Companies

11 South America Protein Engineering Market Analysis and Outlook To 2030
11.1 Introduction to South America Protein Engineering Markets in 2024
11.2 South America Protein Engineering Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Protein Engineering Market size Outlook by Segments, 2021-2030
By Product
Instruments
Reagents
Software & Services
By Technology
Rational Protein Design
Directed Evolution
Hybrid Approach
De Novo Protein Design
Others
By Protein
Insulin
Monoclonal Antibodies
Vaccines
Growth Factors
Colony Stimulating Factors
Coagulation Factors
Interferon
Others
By End-User
Academic Research Institutes
Contract Research Organizations (CROs)
Pharmaceutical & Biotechnology Companies
12 Middle East and Africa Protein Engineering Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Protein Engineering Markets in 2024
12.2 Middle East and Africa Protein Engineering Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Protein Engineering Market size Outlook by Segments, 2021-2030
By Product
Instruments
Reagents
Software & Services
By Technology
Rational Protein Design
Directed Evolution
Hybrid Approach
De Novo Protein Design
Others
By Protein
Insulin
Monoclonal Antibodies
Vaccines
Growth Factors
Colony Stimulating Factors
Coagulation Factors
Interferon
Others
By End-User
Academic Research Institutes
Contract Research Organizations (CROs)
Pharmaceutical & Biotechnology Companies

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Agilent Technologies Inc
Amgen Inc
Bio-Rad Laboratories Inc
Bruker Corp
Danaher Corp
GenScript Biotech Corp
Merck KGaA
PerkinElmer Inc
Thermo Fisher Scientific Inc
Waters Corp

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Instruments
Reagents
Software & Services
By Technology
Rational Protein Design
Directed Evolution
Hybrid Approach
De Novo Protein Design
Others
By Protein
Insulin
Monoclonal Antibodies
Vaccines
Growth Factors
Colony Stimulating Factors
Coagulation Factors
Interferon
Others
By End-User
Academic Research Institutes
Contract Research Organizations (CROs)
Pharmaceutical & Biotechnology Companies
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)